Savarirayan, R. Et Al. 2021. Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. GENETICS IN MEDICINE , vol.23, no.12 , 2443-2447.

Savarirayan, R., Tofts, L., Irving, M., Wilcox, W. R., Bacino, C. A., Hoover-Fong, J., ... Font, R. U.(2021). Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. GENETICS IN MEDICINE , vol.23, no.12, 2443-2447.

Savarirayan, Ravi Et Al. "Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study," GENETICS IN MEDICINE , vol.23, no.12, 2443-2447, 2021

Savarirayan, Ravi Et Al. "Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study." GENETICS IN MEDICINE , vol.23, no.12, pp.2443-2447, 2021

Savarirayan, R. Et Al. (2021) . "Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study." GENETICS IN MEDICINE , vol.23, no.12, pp.2443-2447.

@article{article, author={Ravi Savarirayan Et Al. }, title={Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study}, journal={GENETICS IN MEDICINE}, year=2021, pages={2443-2447} }